Interleukin Inhibitors and Risk of Cancer, Serious or Opportunistic Infections
Interleukin 1 family | Interleukin 1 inhibitors | proinflammatory cytokines
Cytokines
Immunology - Interleukin 1 (IL1) physiology and IL1 antagonist pharmacology
Immunology - Interleukin 6 (IL6) physiology and IL6 antagonist pharmacology Tocilizumab
IL6 Targeting
5 Supplements To Inhibit IL-11
Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors
COVID-19 and Interleukin-6 & Janus Kinase Inhibitors Lecture
Human Kinome as Target for Autoimmune and Autoinflammatory Disease
Mechanism of Action of JAK Inhibitors
Interleukin 6 | Interleukin 6 signaling | Interleukin 6 inhibitors | USMLE
IL23 & IL12/23 Inhibitors: An Overview
COVID-19 | Interleukin Receptor Inhibitors
Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing MAPK-AP-1 Pathway
Interleukin-11 as a therapeutic target for mammalian healthspan | Prof Stuart Cook
Tumour immunology and immunotherapy
Interleukin functions -mnemonic | Immunology | #shorts
WCH23: IL-17 vs IL-23 Blockers – Why and When?
Understanding the mechanisms of action of new agents: Implications for efficacy and safety